Evidence map›Paper›PMID 30962333›Full record

ArticleAntimicrobial agents and chemotherapy2019

Emergence of IMP-34- and OXA-58-Producing Carbapenem-Resistant Acinetobacter colistiniresistens.

Yuki Suzuki, Shiro Endo, Ryuichi Nakano, Akiyo Nakano, Kyoichi Saito, Risako Kakuta, Naoki Kakuta, Saori Horiuchi, Hisakazu Yano, Mitsuo Kaku

Abstract readLetter
In one paragraph

Article in Antimicrobial agents and chemotherapy, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Review
  2. Review
  3. Identification and characterisation of colistin-resistantNew microbes and new infections · 2024
    Article
  4. Does Emerging Carbapenem Resistance inInfectious disease reports · 2023
    Review
  5. Antibiotics (Basel, Switzerland) · 2023
    Article
  6. Article
  7. Frontiers in microbiology · 2022
    Article
  8. Coexistence ofFrontiers in microbiology · 2020
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Yuki Suzuki *Department of Infection Control and Laboratory Diagnosis, Internal Medicine, Tohoku University Graduate School of Medicine, Miyagi, Japan.
Shiro Endo *Department of Infection Control and Laboratory Diagnosis, Internal Medicine, Tohoku University Graduate School of Medicine, Miyagi, Japan.
Ryuichi NakanoDepartment of Microbiology and Infectious Diseases, Nara Medical University, Nara, Japan rnakano@naramed-u.ac.jp.
Akiyo NakanoDepartment of Microbiology and Infectious Diseases, Nara Medical University, Nara, Japan.
Kyoichi SaitoDepartment of Infection Control and Laboratory Diagnosis, Internal Medicine, Tohoku University Graduate School of Medicine, Miyagi, Japan.
Risako KakutaDepartment of Infection Control and Laboratory Diagnosis, Internal Medicine, Tohoku University Graduate School of Medicine, Miyagi, Japan.
Naoki KakutaDepartment of Microbiology and Infectious Diseases, Nara Medical University, Nara, Japan.
Saori HoriuchiDepartment of Microbiology and Infectious Diseases, Nara Medical University, Nara, Japan.
Hisakazu YanoDepartment of Microbiology and Infectious Diseases, Nara Medical University, Nara, Japan.
Mitsuo KakuDepartment of Infection Control and Laboratory Diagnosis, Internal Medicine, Tohoku University Graduate School of Medicine, Miyagi, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

AcinetobacterAnti-Bacterial AgentsCarbapenemsAnti-Bacterial AgentsCarbapenemsAcinetobacter colistiniresistenscolistin resistanceIMP-34OXA-58

Identifiers

PMID30962333
PMCPMC6535544

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.